MedPath

Perioperative methadone compared to placebo in elderly hip fracture patients – a randomized controlled trial. Phase two of the MetaHip trial

Phase 1
Recruiting
Conditions
Hip fractures
MedDRA version: 20.1Level: LLTClassification code: 10053653Term: Femur fracture subtrochanteric Class: 10022117
MedDRA version: 20.0Level: LLTClassification code: 10017216Term: Fracture of subtrochanteric section of femur closed Class: 10022117
MedDRA version: 20.0Level: LLTClassification code: 10017096Term: Fracture of base of neck of femur closed Class: 10022117
MedDRA version: 20.0Level: LLTClassification code: 10017163Term: Fracture of neck of femur Class: 10022117
MedDRA version: 20.1Level: LLTClassification code: 10017236Term: Fracture of unspecified part of neck of femur closed Class: 10022117
MedDRA version: 20.0Level: LLTClassification code: 10017228Term: Fracture of unspecified intracapsular section of neck of femur closed Class: 10022117
MedDRA version: 20.1Level: LLTClassification code: 10034736Term: Pertrochanteric fracture of femur closed Class: 10022117
MedDRA version: 20.0Level: LLTClassification code: 10017159Term: Fracture of midcervical section of femur closed Class: 10022117
MedDRA version: 20.0Level: LLTClassification code: 10017130Term: Fracture of intertrochanteric section of femur closed Class: 10022117
Registration Number
CTIS2023-506252-24-00
Lead Sponsor
Sygehus Soenderjylland Soenderborg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
130
Inclusion Criteria

Patients diagnosed with an acute hip fracture (incurred <24 hours ago) on x-rays in the emergency department. This includes collum femoris fractures, pertrochanteric fractures, and subtrochanteric fractures., Age = 60 years.

Exclusion Criteria

Multiple fractures., Previous allergic reactions or hypersensitivity towards methadone hydrochloride or sodium chloride., Health conditions preventing treatment: •Chronic obstructive pulmonary disease with either past exacerbations or daily symptoms •History of acute asthma attacks •History of drug-induced eczema •Pulmonary hypertension •Raised intracranial pressure or recent head injury •Pheochromocytoma •History of paralytic ileus •QT-interval prolongation on electrocardiogram (ECG) •Myasthenia gravis •Known liver disorder •Hypotension (systolic blood pressure <100 mmHg at admission)., Concurrent administration with MAO inhibitors or within 2 weeks of suspending treatment with these medicinal products., Concurrent administration of benzodiazepines., Impaired cognitive function e.g. dementia. Patients must be able to give informed consent and be able to ask for supplementary analgesics if needed., Current opioid addiction or intravenous addiction., Multi-trauma patient

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To investigate the analgesic effect of a single dose of methadone compared with a placebo in acute hip fracture surgery.;Secondary Objective: To investigate the long-term effects of methadone on continued opioid consumption, pain, and mobility three months after surgery.;Primary end point(s): Daily consumption of opioids
Secondary Outcome Measures
NameTimeMethod
Secondary end point(s):Pain;Secondary end point(s):Standing up;Secondary end point(s):Mobility;Secondary end point(s):Nausea or vomiting;Secondary end point(s):Time to discharge;Secondary end point(s):Need for an antidote;Secondary end point(s):Delirium;Secondary end point(s):Constipation
© Copyright 2025. All Rights Reserved by MedPath